Announced its financial and operational results for the second-quarter 2026 period ending September 30, 2025. The company expands YoY Global Medical Cannabis Net Revenue by 15% to a record $70.5 million. It also increases International Medical Cannabis Net Revenue by 22% to Record $42.7 million, and delivered Adjusted EBITDA growth of 52%, reaching $15.4 million. Aurora Cannabis Inc. shares T.ACB are trading unchanged at $6.42.
Stocks in play: Aurora Cannabis Inc.
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
/Intel%20Corp_%20logo%20on%20mobile%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
/An%20image%20of%20a%20Tesla%20humanoid%20robot%20in%20front%20of%20the%20company%20logo%20Around%20the%20World%20Photos%20via%20Shutterstock.jpg)
/Alphabet%20(Google)%20Image%20by%20Markus%20Mainka%20via%20Shutterstock.jpg)
/Nvidia%20logo%20by%20Konstantin%20Savusia%20via%20Shutterstock.jpg)
/Micron%20Technology%20Inc_%20logo%20on%20building-by%20vzphotos%20vis%20iStock.jpg)